You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 667 Predictive value of circulating tumor DNA in patients with advanced HPV16-positive cervical cancer treated with VB10.16 in combination with atezolizumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
667 Predictive value of circulating tumor DNA in patients with advanced HPV16-positive cervical cancer treated with VB10.16 in combination with atezolizumab

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023162015
Dec 20233007
Jan 20243107
Feb 2024801
Mar 20243404
Apr 20244203
May 20243200
Jun 20242002
Jul 20243002
Aug 20243001
Sep 202452014
Oct 20242601
Nov 20243204
Dec 20247608
Jan 20252603
Feb 20251802
Mar 2025002
Apr 2025004
May 2025004
Jun 2025003
Total649087